Skip to main content

Table 3 Long-term outcomes in non-frail vs frail patients

From: Relevance of presenting risks of frailty, sarcopaenia and osteopaenia to outcomes from aneurysmal subarachnoid haemorrhage

 

Unadjusted

Adjusted

   

Overall

Non-Frail

(n = 20)

Frail

(n = 31)

OR (95% CI)

P Value

OR (95% CI)

P Value

mRS

3 months

Median (1Q – 3Q)

1 (0 – 3)

1 (0 – 1)

2 (1 – 4)

-

0.005

-

0.015

1 year

Median (1Q – 3Q)

0 (0 – 2)

0 (0 – 1)

1 (0 – 4)

-

0.038

-

0.064

Favourable mRS

3 months

Frequency (%)

39 (76.5)

19 (95.0)

20 (64.5)

10.5 (1.23 – 88)

0.017

9.01 (1.02 – 79)

0.048

1 year

Frequency (%)

42 (82.4)

19 (95.0)

23 (74.2)

6.61 (0.76 – 57)

0.072

5.21 (0.54 – 50)

0.15

Mortality

30 day

Frequency (%)

1 (2.0)

0 (0)

1 (3.2)

-

1.00

-

1.00

6 months

Frequency (%)

1 (2.0)

0 (0)

1 (3.2)

-

1.00

-

1.00

1 year

Frequency (%)

2 (3.9)

0 (0)

2 (6.5)

-

0.52

-

1.00

3 year

Frequency (%)

3 (5.9)

0 (0)

3 (9.7)

-

0.29

-

1.00

5 year

Frequency (%)

5 (9.8)

0 (0)

5 (16.7)

-

0.14

-

1.00

  1. mRS Modified Rankin scale